We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Allergic Reactions From Drug-Eluting Stents

By HospiMedica staff writers
Posted on 18 Jan 2006
Drug-eluting stents, which can greatly reduce the risk of restenosis, can cause allergic reactions with serious consequences, including death, according to new findings.

Researchers from Northwestern Memorial Hospital (Chicago, IL, USA) reviewed 5,783 reports from 10 centers nationwide and identified 17 cases of hypersensitivity reactions that were classified as probably or certainly caused by drug-eluting stents, four of which resulted in death. More...
Symptoms included rash, difficulty breathing, hives, itching, and fevers. The researchers concluded that the polymer coating on the stent is the most probable cause of hypersensitivity in the majority of cases rather than the medications coating the stent.

The findings were published in the January 3, 2006, issue of the Journal of the American College of Cardiology. The researchers also concluded that further research is warranted to better understand this risk and to develop a skin test to identify people who might be at high risk for hypersensitivity to drug-eluting stents.

"It is important to keep the findings in perspective,” said Dr. Charles J. Davidson, an author on the paper and professor of medicine at Northwestern University's Feinberg School of Medicine. "Drug-eluting stents are a life-saving advance used by hundreds of thousands of people that have greatly reduced the risk of restenosis. We are in no way recommending they be used less, but we do think that health professionals should be vigilant in watching for this problem.”

The study was based on reports from the Research Adverse Drug/Device Events and Reports (RADAR) Project, which compiles information from reports submitted to the database of the U.S. Food and Drug Administration's (FDA) as well as reports by drug companies and independent researchers throughout the world.




Related Links:
Northwestern Memorial Hospital

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.